FP7 Health presentation

1
Health Work Programme 2011- FP7 (5th year calls)
??????? ????????? ????????-2011-7?? (5-?
???????)
?????????? ???????? ??????????? ?????????? ??
????? ??????????? ????????
June 2009
2
HEALTH-NCP-NET ??? ????, ????????????
???????????? ?????????? ????? (???) ??
????????????? ??????????? ???????? ? ?????? ?
?????????? ????? ?? ?? ?????????.
???? ???????????? ?? ????????????? ???????????
???????? http//cordis.europa.eu/fp7/health/hom
e_en.html
???????????? ?????????????? ???? 7 ?? ?? ?
???????? http//fp7-nip.org.by/ ????????????
????? ?????????? ????? ??????????? ???. 375 17
2867630 e-mailmeerovskaya_at_fp7-nip.org.by
3
??? ???????? ????????? ? ????????? ?????????
??? ???????? ???????????? ?????????? ????? 7??
?? ?? ????????????? ??????????? ????????
?. ?????, ??. ?????????????, 27 e-mail
ipb_at_biobel.bas-net.by http//ibp.org.by/ru/?page_i
d229 ???. 375 17 284 15 68 375
17 284 23 57 ???? 375 17 284 23 59

• ???????? ???????????????? ???????? ?? ????? ?
  ??????????? ?? 16 ????? 2007 ?. ? 28 ? ????????
  ??????-???????????? ?????????????? ? ???????????
  ?????? ???????? ????????? ? ????????? ?????????
  ???????? ???????????? ?????????? ?????? (???) 7??
  ?? ?? ????????????? ??????????? ????????.
• ???????? ??????????? ????????????
• ??????????????? ?????????? ? ???????????? ???????
  ??????????? ?????? ? ???????? 7 ????????
  ?????????.
• ???????????????? ??????????? ? ?????????????
  ?????????? ?? ???????? ?? ???????? ??????????
  ?????? ? ?????????? ????????.
• ????? ????????? ? ??????? ?? ??? ???????????
  ???????????, ???????? ?????????????? ?
  ????????????? ????????????, ? ???????? ?????
  ????????? ? ???????? ?? ???????? ??????????? ??
  ??.
• ??????? ??????-???????????? ?????????? ???????? ?
  ??????? ?? ??? ??????????? ??????? ?????????????
  ?????? ? ???????? 7 ??.
• ?????????? ?????????????? ???? ? ?????????.

4
???? ????????7?? ???????????? ?????

• Cooperation (??????????????)
• Ideas (????)
• ??ople (????) -
• Capacities (c??????????)
• Joint Research Projects (?????????? ??????.
  ???????)
• Euroatom (????????)

5
?????????? ??????? ? ????-??-???????????
???????????? ???????????? ?????

• 1.Energy (?????????? )
• 2.Environment (including Climate Change)
  (?????????? ?????, ??????? ????????? ???????)
• 3.Food, Agriculture and Fishery, Biotechnology
  (???????, ???????? ? ?????? ?????????,????????????
  ?)
• 4.?ealth(????????)
• 5. Information and Communication Technologies
  (?????????????? ? ???????????????? ??????????)
• 6. Nanosciences, Nanotechnologies, Materials and
  new Production Technologies (?????????,
  ??????????????, ????????? ? ?????
  ???????????????? ?????????? )
• 7. Socio-economic sciences and Humanities
  (?????????-????????????? ? ???????????? ?????)
• 8. Transport (including Aeronautics) (?????????,
  ??????? ???????????)
• 9. Security (????????????)
• ?? ??????????? ???????????? ????????? ?????????
  ????????

6
????? ???????-???????

• Collaborative projects (?????????? ???????)
• Networks of excellence (???? ?????????????)
• Coordination and support actions (?????? ??
  ??????????? ? ?????????)
• Individual projects (?????????????? ???????)
• Support for training and career development of
  researches (????????? ????????????????? ?
  ?????????? ????? ??????????????)

7
?????????? ???????

• ??????????? ????????????? ?? ????-??????????
  ????????? ?????, ??????? ?????????? ??????
  ????????? ????? ??????, ???????? ????? ??????????
  ? ?????????, ??????????? ? ?????? ??????????? ??
  ????????? ?????, ?????????? 3 ???? ??????????
  ???????? (?????, ??????? ? ???????), ???????
  ????? ???? ????????????? ?? ??????-????? ??????,
  ????????, SME.

8

• ???? ?????????????
• ???????????? ?????????? ????????? ????
  ??????????? (Joint Programme Activities),
  ???????????? ???? ???????????? ? ????-????????
  ??????? ???????????? ? ???? ?????????? ??????????
• ?????? ?? ??????????? ? ?????????
• ???????????? ???????????? ?? ??????????? ?
  ????????? ??????? ???????????? (???????? ?????,
  ?????? ??????? ? ???????????, ?????????????????
  ?????? ? ??????????????? ? ?????????????,
  ?????????? ???????????)

9

• ?????????????? ???????
• ?????????????? ????????????? ??? ??????????????
  ???????? ?????? ?? ????? ?????????? ???????
  ????????-???? ?? ?????????????? ? ???????????
  ??????-????????????????? ???????
• ????????? ????????????????? ? ?????????? ?????
  ??????
• ?????????????? ????? ??????? ??????? ??. ?????
  ????

10
???? 7??

• ? ?????? ????? Coordination and Support Action
  ???????????? ??????? ??? ?????
• IncoNet EECA http//www.inco-eeca.net
• IncoNet CA/SC - ST International Cooperation
  Network for Central Asian and South Caucasus
  Countries http//icbss.org/index.php?optioncom_co
  ntenttaskviewid273
• incrEAST - Information Exchange in Science and
  Technology between the European Research Area and
  Eastern European / Central Asian Countries
  http//www.increast.eu/
• HEALTH-NCP-NET http//www.healthncpnet.eu/jahia/Ja
  hia/
• INCONTACT network of the INCO-NCPs
  http//www.ncp-incontact.eu/nkswiki/index.php?titl
  eMain_Page
• HITT-CIS - Health In Times Transition Trends in
  Population Health and Health Policies in CIS
  countries http//www.hitt-cis.net/

11

• ERA-NETs
• ERA.NET RUS Linking Russia to the ERA
  Coordination of MS/AC ST programmes towards
  and with Russia http//www.era.net-rus.eu/,
  http//ec.europa.eu/research/iscp/pdf/russia_erane
  t.pdf
• BS-ERA.NET Networking on science and technology
  in the Black Sea region http//www.bs-era.net/main
  /index.php?we9bfdbe988abcff430168e60524a69c11wch
  kc1960ad06e70dbaee80ab8641db51532,
  http//ec.europa.eu/research/iscp/pdf/black_sea.pd
  f
• BILATs
• BILAT-RUS Enhancing the bilateral ST Partnership
  with the Russian Federation http//www.bilat-rus.e
  u/, http//ec.europa.eu/research/iscp/pdf/russia_b
  ilat.pdf
• BILAT-UKR Enhancing the bilateral ST Partnership
  with Ukraine, http//www.bilat-ukr.eu/,
  http//ec.europa.eu/research/iscp/pdf/ukraine.pdf

12
Participation and Success Rate in FP7 Health
Research

• The countries of Eastern Europe and Central Asia
  include Armenia, Azerbaijan, Belarus, Georgia,
  Kazakhstan, Kyrgyzstan, Moldova, the Russian
  Federation, Turkmenistan, Tajikistan, Ukraine and
  Uzbekistan. (EECAlink focuses on those
  underlined)
• FP6 Armenia (3 - 250k), Belarus (1 -
  22k),Ukraine (8 - 650k), Russia (38 - 5.8Mio)
• FP7 Armenia (8/2/25), Belarus (12/2/17)
  ,Georgia (10/4/40), Kazakhstan (9/2/22),
  Moldova (7/3/43), Russia (113/25/22),
• Ukraine (28/5/18), Uzbekistan (2/1/50)CPM
  Status March 2010

13
5-?? ??????? ????????

• ?????? 650m
• ???? ?????????? 30 July 2010
• ????????? ???? ???????? ????????
• FP7-HEALTH-2011-single-stage, deadline 10 Nov.
  2010 (tbc)
• FP7-HEALTH-2011-two-stage, deadline 13 Oct. 2010
  (tbc)

14
????????? ?????? ?? 7?? ????????

• FP7 HEALTH
• Proposals received ??? ??????- 21829 ,
  ?????? ?????? 1464
• N of participations
  2315 591
• Grant Agreements
  405
  123
• (N of participations
  4241 327
• EU funding 1606 Mio

15
?????????? 5-??? ????????

• ??????? ??????? ???????????
• the brain neurodegenerative lifestyle-related
  aspects
• diabetes/obesity lifestyle-induced conditions
• antimicrobial drug resistance
• emerging epidemics
• health inequalities,
• ????????????????? ?????????? ??????? ??????????
• Epigenomics
• Better immunisation

16

????????????????? ?????????? ??????? ??????????

• Major strategic investments to foster European
  competitive position in target areas with
  important economical/societal return
• Programmatic approach (structuring the ERA)
  several research components integrated in each
  project, allowing synergies.
• High-impact outcomes expected from coherent
  ambitious strategies
• Collaborative Project, but larger in size (30
  Mio)
• Participation of SMEs (min. 15 of EU
  contribution to each project)
• Governance and management will be critical.
• Adapted evaluation single-stage, with hearings

17
???????? ??????????? ?????????

• ??????????? ????????
• ???????????? ????? ????????
• ????? EC max. 6m/project in most cases
• ?????? ????????? ? ?????? ?????? ???? (with
  minimum 3)
• ????????????????? ???????? ?? ??????????
  ??????????
• ?????????? ??????? ???????
• ????????????? ????????? ??????? (EU and national)
• ???????? ??????? ??????????????

18
???????? ??????????? ?????????

• ????
• Translating research into clinical practice
• Focus on investigator-driven CTs relevant to
  public health

19
SME ???????

• ???? ?? ????? ????????? ? ?????????
  ??????? SME

20
???????? ???????-??????? ??????????????

• ??????? ?? ????? ??????, ??????-?? ?????????
  ??????? ? ?????? ?????
• ???????? ???????? ???????????? ??????????? ???
  ??????????? ????? (??????? ? ??????)
• ??????? ??????? (???, ??????, ???-?????-??????????
  ??????????? ? ??. ) ???????? ?????????
  ????????-????? ????? ?, ???????? (???????,
  ??????????,).
• ??????? ?????? ????????????

21

• ??? ???? ??????? ??? ?????????? ?? ??????? ?????
• ????????? ???? ????? ??????? ????????
• ??? ??? ??????? ???????? Specific International
  Cooperation Actions (??? ?????????? SICAs)
• Address specific issues that partner countries
  face or have a global character, on the basis of
  mutual interest and benefit

22
???????? ??????? ??????

• ??????????? ?????? ???? ?????????? ????????,
  ??????? ?????????, ??????????? ?? ?????????????
  (not wishful thinking)
• ?????????? ????????? ?????? ???? ???????????? ?
  ??????????????? ??????? (select the right
  partners)
• ??????????? ?????? ??????????????? ???? ?????????
  ?????????
• ?????? ???? ????????????? ??? ?????????? (dont
  rely on reputation)
• ?????????????? ???????? ???????? (deadlines, N
  of participants, ceilings, length, ethics

23

• 3 ???????? ????????????
• ??????
• Science Technology excellence 3/5
• Implementation Management 3/5
• Potential Impact 3/5
• Overall
  10/15

24
??????????? ????????????????? ???????????? (RD
aria)

• 27 EU Member States
• 7 Outermost Regions
• Guadeloupe, French Guiana, Martinique and Réunion
  (the four French overseas departments), the
  Canaries (Spain), and the Azores and Madeira
  (Portugal)
• 12 Associated Countries(the EU neighbourhood
  countries)
• Albania, Bosnia and Herzegovina, Croatia, Iceland
  , Israel, Liechtenstein, FYR of Macedonia,
  Norway, Republic of Montenegro, Serbia,
  Switzerland, Turkey
• FP7 Third Countries
• Other countries worldwide - can participate in
  FP7
• - some can receive funding (ICPC, incl. BRICS)
  and others only exceptionally (high-income
  countries)

25
(No Transcript)
26
??????? ??????? ?????
27

• ??????? ??????????????????? ????? (2007-2010)
• Russia 35
• Ukraine 6
• Georgia 5
• Rep.Moldova 4
• Belarus 3
• Armenia, Kazakhstan 2
• Uzbekistan 1

28
?????????? ? ??????????????

• ??? ??????????? ????? ???????? (CP-IPs,
  small/medium CP-FPs)
• ??????????? ????? ?????????? 3 ?? MS/AS
• ??????? ????? ??????? CP-IPs 10.7 Mio /17
  partners, ??????? CP-FP - 3.5 Mio / 10 partners,
  ????? CP-TP 3.2 Mio / 8 partners
• ??????? ?????????? ??????? ??????? ????? 30 ??
  ???????, 8 ?? ??????????
• Specific International Cooperation Actions
• ??????????? ????? ?????????? 22 (2 from MS/AS
  2 from ICPCs)
• ? ??????? ?? ??????? ????? 4 partners
• ??????? ????? CP-SICA - 3.4 Mio / 9 partners
  (5 MS/AS 4 TC)

29
??????????? 5-??? ???????? c ????? ??????
??????????????

• Programme-Level Cooperation with
• Russia 1.1-3 HTP Proteomics
• Brazil 1.1.4-5 Inflammatory and Autoimmune
  diseases
• India 2.2.1-4 Neurodegenerative paediatric
  diseases
• India 2.4.1-3 Cancer from Infectious Agents
• Brazil 3.4-3 Multilateral cooperation in Public
  Health
• Specific International Cooperation Actions
• 2.1.1-4 Pop. Genetics on Cardio-Metabolic
  Disorders
• 2.3.3-2 Control of Dengue Fever
• 2.4.3-4 Obesity and/or Diabetes in Specific
  Populations
• 3.4-1 Reproductive Health and Health Equity
• Other topics of particular international nature
• 2.3.3-1 Zoonotic Viruses
• 2.3.3-3 Major Epidemic Outbreaks
• 2.3.1-2 Evolution/transfer of AMDR
• 3.3-1 Determinants of Health
• 3.4-2 Research Capacity

30
??? ?????? ???????????

• Calls for Proposals, Work Programme
  (Topics)http//cordis.europa.eu/fp7/health/
• National Contact Points (NCPs) - Information
  support for applicants http//www.healthncpnet.eu
• FP6/FP7 projects databaseshttp//www.lifecompeten
  ce.eu/ http//www.healthcompetence.eu/
• Partner search toolshttp//www.smesgohealth.org/
• EU health research websitehttp//ec.europa.eu/res
  earch/health/

31

• Proposed topics for 2011 WP
• Activity 1 - ?????????????, ????-?? ?
  ?????????? ??? ????????

32
?????????????, ????-?? ? ??????????

• 1.1 High-throughput research
• 1.1-1 SME-targeted research for developing tools
  and technologies for high-throughput research.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.
• 1.1-2 Genome-based biomarkers for patient
  stratification and pharmacogenomic strategies.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.
• 1.1-3 High-throughput proteomics for human health
  and disease. (Russia)
• Funding scheme collab. project, max 3m,
  single-stage, one or more proposals.

33
?????????????, ????-?? ? ??????????

• 1.2 - Detection, diagnosis and monitoring
• Closed in 2011
• 1.3 - Suitability, safety, efficacy of therapies
• Closed in 2011

34
?????????????, ????-?? ? ??????????

• 1.4 Innovative therapeutic approaches and
  interventions
• 1.4-1 Regenerative medicine clinical trials.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.
• 1.4-2 Tools, technologies and devices for
  application in regenerative medicine.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.
• 1.4-3 Development and production of new,
  high-affinity protein scaffolds for therapeutic
  use.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.

35
?????????????, ????-?? ? ??????????

• 1.4 Innovative therapeutic approaches and
  interventions
• 1.4-4 High impact project immunisation.
• Funding scheme collab. project, max 30m,
  single-stage, max one proposal.
• 1.4-5 New therapeutic approaches in chronic
  inflammatory and autoimmune diseases. (Brazil)
• Funding scheme collab. project, max 3m,
  single-stage, one or more proposals

36

• Proposed topics for 2011 WP
• Activity 2 - ???????? ?????????-??? ? ???????
  ???????? (translating research for human health)

37
???????? ?????????-??? ? ??????? ????????

• 2.1.1 large-scale data-gathering
• 2.1.1-1 High impact initiative on the human
  epigenome.
• Funding scheme collab. project, max 30m,
  single-stage, max one proposal.
• 2.1.1-2 Proteins and their interactions in health
  and disease.
• Funding scheme collab. project, max 12m,
  2-stage, one or more proposals.
• 2.1.1-3 Large-scale genomics approaches to
  identify host determinants of infectious
  diseases.
• Funding scheme collab. project, max 12m,
  single-stage, max one proposal.
• 2.1.1-4 Population genetic studies on
  cardio-metabolic disorders in EU/AC and EECA
  populations.
• Funding scheme Specific International
  Cooperation Action (SICA), collab. project, max
  6m, single-stage, max one proposal.

38
???????? ?????????-??? ? ??????? ????????

• 2.1 Integrating biological data and processes
• 2.1.2 Systems biology
• Closed in 2011.

39
???????? ?????????-??? ? ??????? ????????

• 2.2.1 Research on the Brain and related
  diseases, human development and ageing
• 2.2.1-1 Investigator-driven clinical trials for
  childhood-onset neurodegenerative diseases.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.
• 2.2.1-2 Understanding the role of
  neuroinflammation in neurodegenerative diseases.
• Funding scheme collab. project, max 12m,
  2-stage, one or more proposals.
• 2.2.1-3 Addictive and/or compulsive behaviour in
  children adolescents translating preclinical
  results into therapies
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.

40
???????? ?????????-??? ? ??????? ????????

• 2.2.1 Research on the Brain and related
  diseases, human development and ageing
• 2.2.1-4 Creating clinical and molecular tools for
  experi-mental therapy of paediatric
  neurodegenerative disorders causing childhood
  dementia in Europe and India.
• Funding scheme collab. project, max 3m,
  single-stage, one or more proposals.
• 2.2.1-5 ERA-Net on disease-related
  neuroscien-ces.
• Funding scheme CA ERA-NET, 2m, single-stage,
  max. one proposal.

41
???????? ?????????-??? ? ??????? ????????

• 2.2.2 Human development and ageing
• 2.2.2-1 Investigator-driven clinical trials for
  therapeutic interventions in elderly populations.
  
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.
• 2.2.2-2 Linking human development and ageing.
• Funding scheme collab. project, max 3m,
  2-stage, one or more proposals.

42
???????? ?????????-??? ? ??????? ????????

• 2.3-1 Anti-microbial drug resistance
• 2.3.1-1 Investigator-driven clinical trials of
  off-patent antibiotics.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.
• 2.3.1-2 Multi-disciplinary research on the
  evolution and transfer of antibiotic resistance.
• Funding scheme collab. project, max 12m,
  single-stage, max one proposal.
• 2.3.1-3 Management of Gram negative multi-drug
  resistant infections.
• Funding scheme collab. project, max 12m,
  single-stage, max one proposal.

43
???????? ?????????-??? ? ??????? ????????

• 2.3-1 Anti-microbial drug resistance
• 2.3.1-4 Development of multi-analyte diagnostic
  tests.
• Funding scheme collab. project, max 3m,
  2-stage, one or more proposals.
• 2.3.1-5 Development of tools to control microbial
  biofilms with relevance to clinical drug
  resistance.
• Funding scheme collab. project, max 3m,
  2-stage, one or more proposals.

44
???????? ?????????-??? ? ??????? ????????

• 2.3.2 HIV/AIDS, malaria and tuberculosis
• Closed in 2011

45
???????? ?????????-??? ? ??????? ????????

• 2.3.3 Potentially new and re-emerging epidemics
• 2.3.3-1 Identification of factors promoting the
  emergence of pathogens with human pandemic
  potential from pathogens with a zoonotic
  background and related prevention strategies.
• Funding scheme collab. project, max 12m,
  two-stage, max one proposal.
• 2.3.3-2 Comprehensive control of Dengue fever
  under changing climatic conditions. (SICA Latin
  Am. Asia)
• Funding scheme collab. project, max 6m,
  single-stage, one or more proposals.
• 2.3.3-3 Development of an evidence-based
  behavioural and communication package to respond
  to major epidemic outbreaks.
• Funding scheme collab. project, max 2m,
  2-stage, one or more proposals.

46
???????? ?????????-??? ? ??????? ????????

• 2.3.4 Neglected infectious diseases
• Closed in 2011

47
???????? ?????????-??? ? ??????? ????????

• 2.4.1 Cancer
• 2.4.1-1 Investigator-driven, treatment trials for
  rare cancers.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.
• 2.4.1-2 Translational research on cancers with
  poor prognosis
• Funding scheme collab. project, max 3m,
  2-stage, one or more proposals.
• 2.4.1-3 Epidemiology and aetiology of
  infection-related cancers (in Europe India)
• Funding scheme collab. project, max 3m,
  1-stage, one or more proposals.

48
???????? ?????????-??? ? ??????? ????????

• 2.4.2 Cardiovascular disease
• 2.4.2-1 Investigator-driven clinical trials for
  the management of cardiovascular diseases.
• Funding scheme collab. project, max 12m,
  2-stage, one or more proposals.
• 2.4.2-2 Evaluation and validation studies of
  clinically useful biomarkers in prevention and
  management of cardiovascular disease.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.

49
???????? ?????????-??? ? ??????? ????????

• 2.4.3 Diabetes and obesity
• 2.4.3-1 Investigator-driven clinical trials to
  reduce diabetes complications.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.
• 2.4.3-2 Development of novel treatment strategies
  based on knowledge of cellular dysfunction.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.
• 2.4.3-3 Molecular and physiological effects of
  lifestyle factors on diabetes/obesity.
• Funding scheme collab. project, max 6m,
  2-stage, one or more proposals.

50
???????? ?????????-??? ? ??????? ????????

• 2.4.3 Diabetes and obesity
• 2.4.3-4 Genetic and environmental factors in
  obesity and/or diabetes in specific populations.
• Funding scheme SICA (Africa, Asia, Latin
  America, Mediterranean countries), max 3m,
  2-stage, one or more proposals.
• 2.4.3-5 ERA-NET on diabetes prevention and
  treatment.
• Funding scheme ERA-NET CA, 2m, single-stage,
  max one project.

51
???????? ?????????-??? ? ??????? ????????

• 2.4.4 Rare diseases
• Closed in 2011
• 2.4.5 Other chronic diseases
• Closed in 2011

52

• Proposed topics for 2011 WP
• Activity 3 - ??????????? ???-????? ????????
  ??????- (Optimising the delivery of health care)

53
??????????? ???-????? ???????? ??????

• 3.1 Translating the results of clinical
  research outcome into clinical practice
• Closed in 2011
• 3.2 Quality, efficiency and solidarity of
  healthcare systems
• Closed in 2011.

54
??????????? ???-????? ???????? ??????

• 3.3 Health promotion
• 3.3-1 Developing methodologies to reduce
  inequities in the determinants of health.
• Funding scheme collab. project, max 3m,
  2-stage, one or more proposals.
• 3.3-2. Analysis of integrated strategies for
  sustainable behaviour change.
• Funding scheme collab. project, max 3m,
  2-stage, one or more proposals.
• 3.3-3 Developing and implementing methods for the
  transfer of research into policy in the fields of
  health promotion and disease prevention.
• Funding scheme collab. project, max 3m,
  single-stage, max one proposal.
• 3.3-4 A road-map for mental health research in
  Europe.
• Funding scheme CA, max 2m, single-stage, max
  one proposal.

55
??????????? ???-????? ???????? ??????

• 3.4 International public health health
  systems
• 3.4-1 Development and assessment of comprehensive
  and integrated interventions and programmes to
  improve repro-ductive health and health equity.
• Funding scheme SICA (all ICPC) collab. project,
  max 3m, single-stage, one or more proposals.
• 3.4-2 Building sustainable capacity for research
  for health and its social determinants in low and
  middle income countries.
• Funding scheme CA, max 2m, single-stage, one or
  more proposals.
• 3.4-3 Multilateral cooperation between Europe,
  Africa and Latin America on public health and
  health services research.
• Funding scheme CA, max 2m, single-stage, max
  one proposal.

56

• Proposed topics for 2011 WP
• Activity 4 - ??????????? ????????? ? ????? ??
  ?????????? ???????? (support actions response
  to policy need)

57
??????????? ?????????

• 4.1 Coordination and support actions across the
  theme
• 4.1-1 Networking of major research institutions
  to coordinate communication actions aimed at the
  media and the general public.
• Funding scheme CA, max 2m, single-stage, max
  one proposal.
• 4.1-2 Targeting publication bias.
• Funding scheme SA, max 0.5m, single-stage, one
  or more proposals.
• 4.1-3 Linking EU and Latin American policy-making
  institutions in the field of health research.
• Funding scheme CA, max 2m, single-stage, max
  one proposal.
• 4.1-4 Organisation of supporting actions and
  events related to the presidency of the EU.
• Funding scheme SA, max 100,000, single-stage,
  one or more proposals.

58
??????????? ?????????

• 4.2 Responding to EU Policy needs
• 4.2-1 Investigator-driven clinical trials on
  off-patent medicines for children.
• Funding scheme collab. project, max 6m,
  single-stage, one or more proposals.
• 4.2-2 Adverse drug reaction research.
• Funding scheme collab. project, max 3m,
  single-stage, one or more proposals.
• 4.23 New methodologies for clinical trials in
  personalised medicine.
• Funding scheme collab. project, max 3m,
  single-stage, one or more proposals.

59

• ??? ???????? ????????? ? ????????? ????????? ???
  ????????
• Tel. [phone]
• Fax [phone]
• E-mail ibce_at_basnet.by
• WWW http//www.ipb.org.by/
• - ????? ? ?????? ????? ??????????, ? ?????
  ???

60
(No Transcript)
61
(No Transcript)